Top Company News of the Day: Woodside Energy, SoftBank, Microsoft, U.S. Airlines

Woodside Energy CEO Upbeat About Resolving Labor Dispute

Woodside Energy is making good progress toward resolving a labor dispute in Australia that has jolted natural gas markets worldwide, Chief Executive Meg O’Neill said.

SoftBank Chip Unit Arm Files for IPO Likely to Be 2023’s Biggest

Arm raised lofty expectations for its business overall but faces near-term market challenges.

Microsoft Proposes New Deal for Activision

The U.K. Competition and Markets Authority said that Microsoft has submitted a new deal to buy Activision, and a new investigation will be carried out with a deadline for a decision set for October 18.

Deal on China Flights Signals U.S. Airlines’ Stronger Hand

Both sides stay civil even as the Biden administration’s go-slow policy frustrates Beijing’s hopes of a faster aviation-market reopening.

Geely Automobile Posts Flat First-Half Net Profit

Geely Automobile Holdings posted a flat first-half net profit despite higher revenue, as its gross profit margin was hurt by intensifying competition in the automobile market.

BHP’s Profit Falls Sharply on Weaker Commodity Prices

UPDATED: BHP said its annual profit more than halved on a year earlier, reflecting a pullback in commodity prices that has squeezed profits across the industry.

Airbnb Hosts and Guests Scramble as New York Begins Crackdown

New short-term rental regulations could eliminate huge blocks of listings for visitors looking for options beyond hotels.

Zoom’s stock pops 4% on strong earnings, guidance

Zoom Video Communications Inc.’s stock climbed in extended trading Monday, after the videoconferencing company topped expectations across the board with its financial results and forecasts.

Judge Backs U.S. Sanctions on Crypto Platform Tornado Cash

A federal judge in Austin, Texas, sided with the government in a civil lawsuit that was brought by six individuals and financed by crypto exchange Coinbase.

Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin.

Source: Dow Jones Newswires


Posted

in

by

Tags: